Lv1
30 积分 2024-01-04 加入
Ethnic and geographic diversity of chronic lymphocytic leukaemia
2天前
已完结
Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial
5天前
已完结
Survival benefit with second-line combination in endometrial cancer
20天前
已完结
Advances in the management of endometrial cancer
20天前
已完结
Head and neck cancer
1个月前
已完结
Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancers
1个月前
已完结
Developments of MEK inhibitors as future cancer therapies: what have we learned from preclinical and clinical studies?
1个月前
已完结
Survival with Osimertinib plus Chemotherapy in EGFR -Mutated Advanced NSCLC
2个月前
已完结
Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial
3个月前
已完结
Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial
4个月前
已完结
皖公网安备34019202002308
